Provenienza dei contatti di primo grado di Alexander Bausch
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Kinarus AG
Kinarus AG Pharmaceuticals: MajorHealth Technology Part of Kinarus Therapeutics Holding AG, Kinarus AG is a Swiss clinical stage pharmaceutical company that focuses on novel treatments to patients suffering from viral, respiratory and ophthalmic diseases. The company is based in Basel, Switzerland. The company was founded in 2017 by Alexander Bausch, Roger Meier. Alexander Bausch has been the CEO since 2017. Kinarus was acquired by Perfect Holding SA on June 03, 2022.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Alexander Bausch tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Strekin AG
Strekin AG BiotechnologyHealth Technology Strekin AG is a Swiss pharmaceutical company that develops pharmaceuticals, therapeutics, and vaccines. The private company is based in Basel, Switzerland and was founded in 2014. | Biotechnology | Director/Board Member Director/Board Member Chief Operating Officer Director/Board Member Director/Board Member | |
Aurealis Oy
Aurealis Oy BiotechnologyHealth Technology Aurealis Oy operates as a biopharmaceutical company which develops treatment method that improves life for chronic inflammation and cancer sufferers. It develops a proprietary technology, which utilizes genetically modulated probiotics that deliver a variety of therapeutic proteins to diseased tissue, thus modulating local immune system and enabling healing. The company was founded by Dirk Weber and Thomas Wirth in 2010 and is headquartered in Kuopio, Finland. | Biotechnology | Director/Board Member Chairman | |
The Fuqua School of Business | College/University | Masters Business Admin | |
Hänseler AG
Hänseler AG Pharmaceuticals: MajorHealth Technology Hänseler AG manufactures and wholesales pharmaceutical products. It offers liquid, semi-solid and solid drug forms and drug substances in conformity with GMP. The firm manufactures galenical, which includes liquid, semi-solid and solid drug forms; and liquid extracts and tinctures. The company was founded by Edwin Hanseler in 1975 and is headquartered in Herisau, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Helvecura Genossenschaft | Director/Board Member | ||
Artidis AG
Artidis AG Medical SpecialtiesHealth Technology Artidis AG develops nano mechanical biomarkers for rapid cancer diagnostics. The private company is based in Basel, Switzerland. The Swiss company was founded by Marija Plodinec, Marko Loparic, Philipp Oertle, Tobias Appenzeller. Marija Plodinec has been the CEO since incorporation. | Medical Specialties | Director/Board Member | |
Cellestia Biotech AG
Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Sirius Healthcare Partners GmbH
Sirius Healthcare Partners GmbH Investment ManagersFinance Sirius Healthcare Partners GmbH provides independent advice to small and mid-cap healthcare companies, venture capital firms, institutional and private investors. The firm's services include strategic advisory, mergers and acquisition and financing advisory. It serves in the area of biotechnology, medical technology and diagnostics, platform technologies and healthcare markets. The company was founded by Subhasis Roy, Khalid Islam, Ernesto Mancosu, Werner Tschollar, Andreas Vogler and Mikael von Euw and is headquartered in Zurich, Switzerland. | Investment Managers | Founder | |
Novaremed AG
Novaremed AG Pharmaceuticals: MajorHealth Technology Novaremed AG operates as a pharmaceutical company. It develops NEB74S, a molecule for the treatment of chronic pain. The company was founded by Eliahu Kaplan in 2008 and is headquartered in Petah Tikva, Israel. | Pharmaceuticals: Major | Chief Executive Officer | |
NLS PHARMACEUTICS AG | Pharmaceuticals: Major | Director of Finance/CFO | |
Vaccentis AG | Director/Board Member | ||
University of Mumbai | College/University | Graduate Degree | |
University of St. Gallen | College/University | Masters Business Admin | |
PIQUR Therapeutics AG
PIQUR Therapeutics AG Pharmaceuticals: OtherHealth Technology PIQUR Therapeutics AG engages in development of anti-cancer drugs based on the inhibition. Its products include PQR309, PQR620 and PQR5xx. The company was founded by Bernd Giese, Vladimir Cmiljanovic, Andreas Emmenegger, Ralf Rosenow and Matthias Wymann in August 2011 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Other | Director/Board Member | |
Versameb AG
Versameb AG Miscellaneous Commercial ServicesCommercial Services Versameb AG operates as an preclinical-stage biopharmaceutical company. The company was founded by Friedrich Metzger, Roger Meier and Urs Breitenstein in 2018 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Founder | |
Acthera Therapeutics AG
Acthera Therapeutics AG BiotechnologyHealth Technology Acthera Therapeutics AG is a Swiss biotechnology company that develops synthetic lipid membrane vesicles. The private company is based in Basel, Switzerland. The CEOs are Carlo Bertozzi, Pierre-Alain Monnard. The company was founded by Roger Meier. | Biotechnology | Founder | |
Clarena AG
Clarena AG Miscellaneous Commercial ServicesCommercial Services Clarena AG provides business management consultancy services. The private company is based in Basel, Switzerland. The Swiss company was founded by Roger Meier. | Miscellaneous Commercial Services | Founder | |
Nemis Technologies AG
Nemis Technologies AG Miscellaneous Commercial ServicesCommercial Services Nemis Technologies AG provides food safety solutions through their n-light environmental monitoring series. The company is based in Dübendorf, Switzerland and was founded in 2018 by Roger Meier, Arnaud Muller, Mario Hupfeld, and Urs Breitenstein. The Swiss company's E.coli rapid test is a part of this series and enables pathogen detection in food processing. Arnaud Muller has been the CEO since 2018. | Miscellaneous Commercial Services | Founder | |
terreActive AG
terreActive AG Information Technology ServicesTechnology Services Part of Die Schweizerische Post AG, terreActive AG is a company that specializes in soar, security orchestration automation and response, ki, ai. The company is based in Aarau, Switzerland. terreActive was acquired by Die Schweizerische Post AG on July 04, 2023. The Swiss company's Security Operations Center is responsible for protecting the IT security infrastructure and preventing cyber attacks. The company was founded in 1996 by Marc-Yves Bächli, Roger Meier. Urs Rufer has been the CEO of the company since 1999. | Information Technology Services | Founder | |
International Institute for Management Development | College/University | Masters Business Admin | |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Doctorate Degree | |
University of Maine | College/University | Undergraduate Degree | |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Aurealis Pharma AG
Aurealis Pharma AG Miscellaneous Commercial ServicesCommercial Services Part of Aurealis Oy, Aurealis Pharma AG is a Swiss company that provides scientific research and development services. The company is based in Basel, Switzerland. The company was founded by Juha Matti Yrjänheikki. | Miscellaneous Commercial Services | Director/Board Member | |
Swiss Cancer Foundation | Director/Board Member | ||
University of Zurich | College/University | Doctorate Degree | |
Spirig Pharma AG
Spirig Pharma AG Pharmaceuticals: MajorHealth Technology Spirig Pharma AG manufactures and distributes pharmaceutical products. The company was founded in 1948 and is headquartered in Egerkingen, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal | |
Eisai Ltd. (United Kingdom)
Eisai Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai Ltd. is a British company that develops pharmaceutical products. The company is based in Hatfield, UK. The company was founded in 1988. Gary Bryan Hendler has been the CEO of the company since 2008. | Pharmaceuticals: Major | Sales & Marketing | |
Adheron Therapeutics, Inc.
Adheron Therapeutics, Inc. BiotechnologyHealth Technology Adheron Therapeutics, Inc. discovers and develops therapeutic drugs. The firm offers Cadherin-11 antagonists for the treatment of rheumatoid arthritis and fibrotic diseases including pulmonary fibrosis and skin fibrosis. The company was founded by David Lee, Michael B. Brenner, and David L. Castaldi in 2006 and is headquartered in Berkeley, CA. | Biotechnology | Chief Executive Officer | |
CYMABAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
BIOVIE INC. | Biotechnology | Director/Board Member | |
Bullet Biotechnology, Inc.
Bullet Biotechnology, Inc. BiotechnologyHealth Technology Bullet Biotechnology, Inc. develops active immunotherapies to stimulate a person’s own immune system to overcome diseases. Its technology educates the immune system to targeting specific cells that are causing disease. The firm's pipeline includes therapeutic vaccines for cancer, multi-specific antibody capsid products, therapeutic vaccines for autoimmune diseases, and other vaccines. The company was founded by Diego Fonstad, James R. Swartz, Willie Quinn and Thomas Theriault in September 2011 and is headquartered in Redwood City, CA. | Biotechnology | Director/Board Member | |
University of Malaya | College/University | Undergraduate Degree | |
University of London | College/University | Doctorate Degree | |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Translational Research In Oncology | Director/Board Member | ||
Krebsforschung Schweiz | Director/Board Member | ||
SPEXIS AG | Pharmaceuticals: Major | Director/Board Member | |
Mavena International AG
Mavena International AG Pharmaceuticals: MajorHealth Technology Mavena International AG develops, manufactures, and markets medical care products for the treatment of chronic skin conditions. The company is headquartered in Huneberg, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
Hänseler Holding AG | Chairman | ||
Helvecura Cooperative Society | Director/Board Member | ||
Hthc High Tech Home Care AG | Chairman | ||
Ulrich Jüstrich Holding AG
Ulrich Jüstrich Holding AG Investment ManagersFinance Ulrich Jüstrich Holding AG is an investment holding private company based in Walzenhausen, Switzerland. and has subsidiaries in Switzerland and France. The Swiss company operates as an investment holding company. | Investment Managers | Director/Board Member | |
Just Finance AG | Director/Board Member | ||
Nexilis AG
Nexilis AG BiotechnologyHealth Technology Nexilis AG is a Swiss medtech company that specializes in providing cost-effective fixation enhancement for any bone screw. The private company's flagship product is the Immediate Stabilisation System (ISS), which is an implantable polymer sleeve that is moulded around the pedicle screw using ultrasonic energy. Nexilis has a culture built around innovative science, precision, and quality, and has engaged in collaborations with renowned institutions to create safe and easy-to-implement solutions for surgeons. The company was founded by Martin Horst and the CEO is Leanna Caron. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
Svizzera | 34 |
Stati Uniti | 11 |
Regno Unito | 3 |
Finlandia | 2 |
India | 2 |
Settori
Health Technology | 23 |
Consumer Services | 10 |
Commercial Services | 6 |
Finance | 3 |
Technology Services | 3 |
Posizioni
Director/Board Member | 36 |
Chairman | 7 |
Founder | 7 |
Corporate Officer/Principal | 6 |
Chief Tech/Sci/R&D Officer | 6 |
Contatti più connessi
Insiders | |
---|---|
Silvio Inderbitzin | 25 |
Hari Kumar | 14 |
Roger Meier | 9 |
Subhasis Roy | 8 |
Matthew Wright | 5 |
Eugene Tierney | 4 |
Claudia Berger | 4 |
Thierry Fumeaux | 3 |
- Borsa valori
- Insiders
- Alexander Bausch
- Connessioni Società